JP2020117504A5 - - Google Patents

Download PDF

Info

Publication number
JP2020117504A5
JP2020117504A5 JP2020029398A JP2020029398A JP2020117504A5 JP 2020117504 A5 JP2020117504 A5 JP 2020117504A5 JP 2020029398 A JP2020029398 A JP 2020029398A JP 2020029398 A JP2020029398 A JP 2020029398A JP 2020117504 A5 JP2020117504 A5 JP 2020117504A5
Authority
JP
Japan
Prior art keywords
dwgpk
seq
subject
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020029398A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020117504A (ja
JP7284726B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020117504A publication Critical patent/JP2020117504A/ja
Publication of JP2020117504A5 publication Critical patent/JP2020117504A5/ja
Priority to JP2023010162A priority Critical patent/JP2023053978A/ja
Application granted granted Critical
Publication of JP7284726B2 publication Critical patent/JP7284726B2/ja
Priority to JP2024170459A priority patent/JP2025010144A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020029398A 2014-03-26 2020-02-25 環状プロサポシンペプチドおよびその使用 Active JP7284726B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023010162A JP2023053978A (ja) 2014-03-26 2023-01-26 環状プロサポシンペプチドおよびその使用
JP2024170459A JP2025010144A (ja) 2014-03-26 2024-09-30 環状プロサポシンペプチドおよびその使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461970853P 2014-03-26 2014-03-26
US61/970,853 2014-03-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016559300A Division JP6727129B2 (ja) 2014-03-26 2015-03-26 環状プロサポシンペプチドおよびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023010162A Division JP2023053978A (ja) 2014-03-26 2023-01-26 環状プロサポシンペプチドおよびその使用

Publications (3)

Publication Number Publication Date
JP2020117504A JP2020117504A (ja) 2020-08-06
JP2020117504A5 true JP2020117504A5 (OSRAM) 2020-11-12
JP7284726B2 JP7284726B2 (ja) 2023-05-31

Family

ID=54196396

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016559300A Active JP6727129B2 (ja) 2014-03-26 2015-03-26 環状プロサポシンペプチドおよびその使用
JP2020029398A Active JP7284726B2 (ja) 2014-03-26 2020-02-25 環状プロサポシンペプチドおよびその使用
JP2023010162A Pending JP2023053978A (ja) 2014-03-26 2023-01-26 環状プロサポシンペプチドおよびその使用
JP2024170459A Pending JP2025010144A (ja) 2014-03-26 2024-09-30 環状プロサポシンペプチドおよびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016559300A Active JP6727129B2 (ja) 2014-03-26 2015-03-26 環状プロサポシンペプチドおよびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023010162A Pending JP2023053978A (ja) 2014-03-26 2023-01-26 環状プロサポシンペプチドおよびその使用
JP2024170459A Pending JP2025010144A (ja) 2014-03-26 2024-09-30 環状プロサポシンペプチドおよびその使用

Country Status (6)

Country Link
US (4) US10646541B2 (OSRAM)
EP (2) EP4154901A1 (OSRAM)
JP (4) JP6727129B2 (OSRAM)
CN (2) CN106659764B (OSRAM)
AU (4) AU2015235978B2 (OSRAM)
WO (1) WO2015148801A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3056116A1 (en) 2007-06-22 2008-12-31 Randolph Watnick Methods and uses thereof of prosaposin
WO2015148801A1 (en) * 2014-03-26 2015-10-01 Children's Medical Center Corporation Cyclic prosaposin peptides and uses thereof
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832253A (en) 1973-03-21 1974-08-27 Baxter Laboratories Inc Method of making an inflatable balloon catheter
US4667014A (en) 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
GB8518144D0 (en) 1985-07-18 1985-08-21 Univ Belfast Solid phase peptide synthesis
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4794150A (en) 1987-03-11 1988-12-27 Samuel Steel Synthesis of peptide analogs
US5541297A (en) 1988-04-01 1996-07-30 Immunomedics, Inc. Therapeutic conjugates of toxins and drugs
US5180816A (en) 1988-08-24 1993-01-19 Centocor One vial method for labeling protein/linker conjugates with technetium-99M
US5221754A (en) 1989-06-09 1993-06-22 Research Corporation Technologies, Inc. Reagents for rapid peptide synthesis
US5766897A (en) 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
WO1994012520A1 (en) 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
ATE193892T1 (de) 1993-06-29 2000-06-15 Ferring Bv Synthese zyklischer peptide
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
US5700909A (en) 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US5552471A (en) 1994-08-17 1996-09-03 The Perkin-Elmer Corporation Solid support reagents for the synthesis of 3'-Nitrogen containing polynucleotides
US6001966A (en) 1995-10-19 1999-12-14 Proligo Llc Method for solution phase synthesis of oligonucleotides and peptides
US5817752A (en) 1996-06-06 1998-10-06 La Jolla Pharmaceutical Company Cyclic polypeptides comprising a thioether linkage and methods for their preparation
US7176282B1 (en) 1996-09-09 2007-02-13 Zealand Pharma A/S Solid-phase peptide synthesis and agent for use in such synthesis
AU9774698A (en) 1997-09-09 1999-03-29 Regents Of The University Of California, The Inhibition of apoptotis using prosaposin receptor agonists
ATE279430T1 (de) 1998-03-05 2004-10-15 Chiron Corp Verfahren zur verbesserung der serum halbwertszeit von biologisch aktiven molekülen
US7094943B2 (en) 1998-04-27 2006-08-22 Hubert Köster Solution phase biopolymer synthesis
US6638911B1 (en) * 1998-05-05 2003-10-28 Adherex Technologies Inc. Compounds and methods for modulating desmosomal cadherin-mediated functions
JP2002530273A (ja) 1998-07-13 2002-09-17 パーカシュ エス. ギル, 脈管形成および腫瘍増殖の新規インヒビター
AUPP616498A0 (en) 1998-09-25 1998-10-15 University Of Queensland, The Synthesis of cyclic peptides
US6706252B1 (en) 1998-10-30 2004-03-16 Rx/Ibr Corporation Method of treating disease with radioisotopes conjugated to bioactive substances
US20020177551A1 (en) 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US20020168639A1 (en) 2000-09-22 2002-11-14 Muraca Patrick J. Profile array substrates
WO2002028437A1 (en) 2000-10-05 2002-04-11 Ares Trading S.A. Regioselective liquid phase pegylation
AU2003249692B2 (en) 2002-06-03 2008-07-31 The Institute For Systems Biology Methods for quantitative proteome analysis of glycoproteins
US20040219609A1 (en) 2002-07-12 2004-11-04 Day Anthony G. Methods for modulating proteins not previously known as proteases
US7166691B2 (en) 2002-12-20 2007-01-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Saposin C and receptors as targets for treatment of benign and malignant disorders
US20060275274A1 (en) 2003-03-26 2006-12-07 Daria Onichtchouk Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
US7834147B2 (en) 2003-04-28 2010-11-16 Childrens Hospital Medical Center Saposin C-DOPS: a novel anti-tumor agent
GB0318205D0 (en) 2003-08-02 2003-09-03 Albachem Ltd Synthetic method
AU2006242449A1 (en) 2005-04-29 2006-11-09 (Osi) Eyetech, Inc. VEGF variants
US20070099251A1 (en) 2005-10-17 2007-05-03 Institute For Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
US20080090760A2 (en) 2005-12-09 2008-04-17 Todd Hembrough Compositions and Methods for Inhibiting Cellular Proliferation
WO2008080845A1 (en) 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Methods for the synthesis of cyclic peptides
CA3056116A1 (en) * 2007-06-22 2008-12-31 Randolph Watnick Methods and uses thereof of prosaposin
US8027291B2 (en) 2007-09-27 2011-09-27 Wireless Technology Solutions Llc Method and apparatus for transmitting transport channels over a physical channel of a cellular communication system
CA2732108A1 (en) 2008-07-28 2010-02-04 Children's Medical Center Corporation Prominin-1 peptide fragments and uses thereof
AU2010339794B2 (en) 2009-12-17 2016-09-22 Children's Medical Center Corporation Saposin-A derived peptides and uses thereof
EP4306123A3 (en) * 2011-12-22 2024-04-17 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
ES2872403T3 (es) * 2013-03-14 2021-11-02 Childrens Medical Center Péptido Psap para el tratamiento de cánceres que expresan CD36
WO2015148801A1 (en) * 2014-03-26 2015-10-01 Children's Medical Center Corporation Cyclic prosaposin peptides and uses thereof

Similar Documents

Publication Publication Date Title
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
JP2005516885A5 (OSRAM)
JP2010500399A5 (OSRAM)
JP2020023567A5 (OSRAM)
JP2008530245A5 (OSRAM)
JP2019533722A5 (OSRAM)
JP2019194251A5 (OSRAM)
JP2020117504A5 (OSRAM)
JP2012126742A5 (OSRAM)
JP2017523985A5 (OSRAM)
JP2008536483A5 (OSRAM)
JP2006506942A5 (OSRAM)
JP2012115277A5 (OSRAM)
JP2012176978A5 (OSRAM)
JP2014530220A5 (OSRAM)
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
JP2014167010A5 (OSRAM)
JPWO2019156137A5 (OSRAM)
JP2005237328A5 (OSRAM)
JP2017526627A5 (OSRAM)
JP2011528897A5 (OSRAM)
JP2014529399A5 (OSRAM)
JP2019214579A5 (OSRAM)
JP2012529293A5 (OSRAM)
CN111315886A (zh) 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物